BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33956455)

  • 1. Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin via Organic Cation-Selective Transporters.
    Ruan Y; Li X; You L; Chen J; Shen Y; Zhang J; Yuan Y; Kang L; Qin C; Wu C
    Mol Pharm; 2021 Jun; 18(6):2198-2207. PubMed ID: 33956455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms for membrane transport of metformin in human intestinal epithelial Caco-2 cells.
    Horie A; Sakata J; Nishimura M; Ishida K; Taguchi M; Hashimoto Y
    Biopharm Drug Dispos; 2011 Jul; 32(5):253-60. PubMed ID: 21567399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress of pyrilamine-sensitive H~+/OC antiporter].
    Wang XY; Zhang ZR
    Yao Xue Xue Bao; 2016 Jun; 51(6):886-91. PubMed ID: 29878742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
    Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
    J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of frequently used pharmaceutical excipients on the organic cation transporters 1-3 and peptide transporters 1/2 stably expressed in MDCKII cells.
    Otter M; Oswald S; Siegmund W; Keiser M
    Eur J Pharm Biopharm; 2017 Mar; 112():187-195. PubMed ID: 27903454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis.
    Proctor WR; Ming X; Bourdet D; Han TK; Everett RS; Thakker DR
    J Pharm Sci; 2016 Feb; 105(2):484-496. PubMed ID: 26869413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
    Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
    Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.
    Zhou M; Xia L; Wang J
    Drug Metab Dispos; 2007 Oct; 35(10):1956-62. PubMed ID: 17600084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic variation and metformin response.
    Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
    Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
    Bourdet DL; Thakker DR
    Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mPEG
    Zhang Y; Sun M; Jian S; Huang J; Xiao C; Zhang X; Hu R; Si L
    Mol Pharm; 2021 Jul; 18(7):2586-2599. PubMed ID: 34102842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.
    Han TK; Proctor WR; Costales CL; Cai H; Everett RS; Thakker DR
    J Pharmacol Exp Ther; 2015 Mar; 352(3):519-28. PubMed ID: 25563903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of sixteen pharmaceutical excipients on six major organic cation and anion uptake transporters.
    Ma R; Li G; Wang X; Bi Y; Zhang Y
    Xenobiotica; 2021 Jan; 51(1):95-104. PubMed ID: 32544367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice.
    Shirasaka Y; Lee N; Zha W; Wagner D; Wang J
    Drug Metab Pharmacokinet; 2016 Oct; 31(5):385-388. PubMed ID: 27569291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of metformin.
    Graham GG; Punt J; Arora M; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup LC; Kirkpatrick CM; Ray JE; Timmins P; Williams KM
    Clin Pharmacokinet; 2011 Feb; 50(2):81-98. PubMed ID: 21241070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrilamine-sensitive proton-coupled organic cation (H
    Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
    J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goldenseal-Mediated Inhibition of Intestinal Uptake Transporters Decreases Metformin Systemic Exposure in Mice.
    Oyanna VO; Garcia-Torres KY; Bechtold BJ; Lynch KD; Call MR; Horváth M; Manwill PK; Graf TN; Cech NB; Oberlies NH; Paine MF; Clarke JD
    Drug Metab Dispos; 2023 Nov; 51(11):1483-1489. PubMed ID: 37562957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of metformin: variability due to polymorphisms of organic cation transporters.
    Zolk O
    Ann Med; 2012 Mar; 44(2):119-29. PubMed ID: 21366511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
    Okura T; Higuchi K; Kitamura A; Deguchi Y
    Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Investigation, Pharmacokinetics, and Disposition of Imeglimin, a Novel Oral Antidiabetic Drug, in Preclinical Species and Humans.
    Clémence C; Fouqueray P; Sébastien B
    Drug Metab Dispos; 2020 Dec; 48(12):1330-1346. PubMed ID: 33020063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.